188 related articles for article (PubMed ID: 35967393)
1. Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia.
Saláková M; Ludvíková V; Hamšíková E; Kolářová M; Šroller V; Viklický O; Wohlfahrtová M
Front Immunol; 2022; 13():929946. PubMed ID: 35967393
[TBL] [Abstract][Full Text] [Related]
2. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
[TBL] [Abstract][Full Text] [Related]
3. The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients.
Lorant C; Zigmantaviciute J; Ali N; Bonnevier U; Tejde M; von Zur-Mühlen B; Eriksson BM; Bergqvist A; Westman G
BMC Infect Dis; 2024 Feb; 24(1):245. PubMed ID: 38388351
[TBL] [Abstract][Full Text] [Related]
4. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
[TBL] [Abstract][Full Text] [Related]
5. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
[TBL] [Abstract][Full Text] [Related]
6. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
7. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia.
Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Zaaijer HL; Kroes AC; van Zwet EW; Rotmans JI; Feltkamp MC
J Clin Virol; 2017 May; 90():46-51. PubMed ID: 28355579
[TBL] [Abstract][Full Text] [Related]
8. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
9. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
10. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
[TBL] [Abstract][Full Text] [Related]
11. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
Kaur A; Wilhelm M; Wilk S; Hirsch HH
Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population.
Hejtmánková A; Roubalová K; Forejtová A; Žáčková Suchanová J; Forstová J; Viklický O; Španielová H
J Med Virol; 2019 May; 91(5):856-864. PubMed ID: 30609063
[TBL] [Abstract][Full Text] [Related]
13. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study.
Tanriver U; Emmerich F; Hummel JF; Jänigen B; Panning M; Arnold F; Tanriver Y
Clin Transplant; 2022 Jul; 36(7):e14663. PubMed ID: 35368114
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.
Wunderink HF; de Brouwer CS; van der Meijden E; Pastrana DV; Kroes ACM; Buck CB; Feltkamp MCW
J Clin Virol; 2019 Jan; 110():22-28. PubMed ID: 30529638
[TBL] [Abstract][Full Text] [Related]
15. BK and JC polyomavirus infections in Tunisian renal transplant recipients.
Boukoum H; Nahdi I; Sahtout W; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
J Med Virol; 2015 Oct; 87(10):1788-95. PubMed ID: 25952258
[TBL] [Abstract][Full Text] [Related]
16. Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China.
Li P; Cheng D; Wen J; Ni X; Xie K; Li X; Chen J
BMC Nephrol; 2021 Oct; 22(1):328. PubMed ID: 34600511
[TBL] [Abstract][Full Text] [Related]
17. BK DNAemia and native kidney polyomavirus nephropathy following lung transplantation.
Dube GK; Batal I; Shah L; Robbins H; Arcasoy SM; Husain SA
Am J Transplant; 2023 Feb; 23(2):284-290. PubMed ID: 36804135
[TBL] [Abstract][Full Text] [Related]
18. Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication.
Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K; Weseslindtner L
J Clin Virol; 2019 Nov; 120():6-11. PubMed ID: 31505316
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
[TBL] [Abstract][Full Text] [Related]
20. CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?
Rodríguez-Goncer I; Ruiz-Ruigómez M; López-Medrano F; Corbella L; Polanco N; González Monte E; San Juan R; Ruiz-Merlo T; Parra P; Folgueira L; Andrés A; Aguado JM; Fernández-Ruiz M
Transpl Infect Dis; 2021 Aug; 23(4):e13597. PubMed ID: 33751753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
